Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc.
CRBP
337

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is a Phase 3 clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases.

https://www.corbuspharma.com/
USA

Ratings

There are no reviews yet.

Post your review

Directions to listing

Send Message to listing owner

Corbus Pharmaceuticals Holdings Inc.